Literature DB >> 12883265

Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets.

Michele Colombo1, Søren Gregersen, Jianzhong Xiao, Kjeld Hermansen.   

Abstract

BACKGROUND AND AIMS: Ghrelin, a neuropeptide containing 28 amino acids, shows a reciprocal diurnal plasma fluctuation to that of plasma insulin. The aim of this study is to clarify the dose and glucose-dependency of ghrelin on the insulin secretion and to compare its effect with that of other neuropeptides-GLP-1, CART (55-102), CART (55-76), CART (62-76), MCH, orexin A, and B.
MATERIALS AND METHODS: Rat islets were incubated with 1 pmol/l-1 micromol/l of ghrelin, CART fragments, MCH, orexin A or B, or GLP-1 (n = 16-32) in the presence of 16.7 mmol/l glucose. Ghrelin (10 nmol/l) was added to islets at glucose concentrations of 3.3, 6.6, 16.7 and 25 mmol/l, respectively (n = 28-32). Also, INS-1E cells were incubated with ghrelin (1 nmol/l) in the presence of glucose (3.3, 6.6, 16.7, and 25 mmol/l). In addition, we measured the mRNA expression of the ghrelin receptor using RT-PCR.
RESULTS: Ghrelin inhibited insulin secretion from islets and INS-1E cells in a dose- and glucose-dependent manner. Neither 10 pmol/l-1 micromol/l of CART fragments, MCH, orexin A, nor orexin B changed the insulin secretion at 16.7 mmol/l glucose, while GLP-1, as expected, stimulated the insulin release from rat islets. Interestingly, ghrelin receptors were expressed both in islets, INS-1E, MIN 6 and alpha cell Tca-9 lines.
CONCLUSIONS: Ghrelin inhibits the insulin secretion in vitro in a dose- and glucose-dependent manner. Beta cells contain ghrelin receptors. CART fragments did not affect the insulin secretion. Ghrelin may play a physiological role for the regulation of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883265     DOI: 10.1097/00006676-200308000-00009

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  34 in total

Review 1.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

2.  IA-2beta, but not IA-2, is induced by ghrelin and inhibits glucose-stimulated insulin secretion.

Authors:  Asako Doi; Takeshi Shono; Masahiro Nishi; Hiroto Furuta; Hideyuki Sasaki; Kishio Nanjo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

3.  Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Authors:  William S Denney; Gabriele E Sonnenberg; Santos Carvajal-Gonzalez; Theresa Tuthill; V Margaret Jackson
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

Review 4.  Ghrelin regulation of glucose metabolism.

Authors:  Sarah M Gray; Laura C Page; Jenny Tong
Journal:  J Neuroendocrinol       Date:  2019-04-03       Impact factor: 3.627

5.  Ghrelin prevents development of diabetes at adult age in streptozotocin-treated newborn rats.

Authors:  T Irako; T Akamizu; H Hosoda; H Iwakura; H Ariyasu; K Tojo; N Tajima; K Kangawa
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

6.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

7.  Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development.

Authors:  Catherine L Prado; Aimee E Pugh-Bernard; Lynda Elghazi; Beatriz Sosa-Pineda; Lori Sussel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

8.  Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Steven E Kahn; David E Cummings; Matthias H Tschöp; David D'Alessio
Journal:  Diabetes       Date:  2010-06-28       Impact factor: 9.461

9.  Effect of ghrelin on glucose-insulin homeostasis: therapeutic implications.

Authors:  Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  Int J Pept       Date:  2010-02-09

10.  Ghrelin-producing epsilon cells in the developing and adult human pancreas.

Authors:  K M Andralojc; A Mercalli; K W Nowak; L Albarello; R Calcagno; L Luzi; E Bonifacio; C Doglioni; L Piemonti
Journal:  Diabetologia       Date:  2008-12-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.